A Phase I Open Label Followed By A Phase II Randomized, Controlled Study To Assess The Efficacy And Safety Of ABTL0812 In Combination With FOLFIRINOX For First-Line Treatment Of Metastatic Pancreatic Cancer

Brief Summary

Type:
Pancreatic

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT04431258

Study #:
STUDY00147649

Start Date:
May 15, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04431258

View Complete Trial Details & Eligibility at ClinicalTrials.gov